The FBI on Tuesday added a known Mexican drug lord to its notorious "Ten Most Wanted" list of fugitives for a multitude of ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

Indicates growing incidence of cancer among Indian population; five out of top 20 new brand launches are cancer drugs ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...

Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.

FDA-authorized alternatives to brand-name weight loss medications gain traction, offering cheaper options for patients.

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

If Fierce Pharma Marketing’s annual list of the top 10 biggest potential drug launches of the coming year is any indication, ...

Stephen 'tWitch' Boss' mom and brother discussed the aftermath of his 2022 death in a new interview on 'CBS Mornings' ...

Several brand-name drugmakers believe they will withstand any drug pricing impacts from President Donald Trump’s tariffs — ...